agilon health (NYSE:AGL) PT Lowered to $4.00 at Evercore ISI

agilon health (NYSE:AGL) had its target price reduced by Evercore ISI from $7.00 to $4.00 in a report released on Tuesday morning, Benzinga reports. They currently have an in-line rating on the stock.

Several other research firms have also recently weighed in on AGL. Deutsche Bank Aktiengesellschaft cut their target price on agilon health from $5.00 to $4.00 and set a hold rating for the company in a research note on Friday, August 9th. Benchmark reaffirmed a buy rating and issued a $9.00 price objective on shares of agilon health in a research note on Thursday, August 8th. Bank of America cut agilon health from a buy rating to an underperform rating and set a $3.00 target price on the stock. in a research report on Wednesday, October 2nd. Finally, Royal Bank of Canada reissued an outperform rating and issued a $8.00 target price on shares of agilon health in a report on Wednesday, August 7th. Two investment analysts have rated the stock with a sell rating, fourteen have issued a hold rating and four have assigned a buy rating to the stock. Based on data from MarketBeat, agilon health has a consensus rating of Hold and a consensus target price of $8.03.

agilon health Stock Up 6.4 %

Shares of NYSE AGL opened at $3.32 on Tuesday. The stock has a market capitalization of $1.37 billion, a P/E ratio of -4.74 and a beta of 0.54. The stock’s fifty day moving average is $4.19 and its 200 day moving average is $5.32. agilon health has a 52 week low of $2.99 and a 52 week high of $20.37. The company has a debt-to-equity ratio of 0.04, a quick ratio of 1.36 and a current ratio of 1.36.

agilon health (NYSE:AGL) last released its earnings results on Tuesday, August 6th. The company reported ($0.07) EPS for the quarter, meeting the consensus estimate of ($0.07). agilon health had a negative net margin of 5.57% and a negative return on equity of 29.91%. The firm had revenue of $1.48 billion for the quarter, compared to analyst estimates of $1.56 billion. During the same period last year, the firm earned ($0.04) EPS. The business’s quarterly revenue was up 38.7% compared to the same quarter last year. Sell-side analysts forecast that agilon health will post -0.32 earnings per share for the current fiscal year.

Insider Buying and Selling

In related news, CEO Steven Sell bought 20,000 shares of the stock in a transaction that occurred on Thursday, September 12th. The stock was acquired at an average cost of $3.36 per share, with a total value of $67,200.00. Following the transaction, the chief executive officer now directly owns 67,590 shares in the company, valued at approximately $227,102.40. This trade represents a 0.00 % increase in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. 3.20% of the stock is currently owned by insiders.

Institutional Trading of agilon health

A number of institutional investors and hedge funds have recently added to or reduced their stakes in AGL. Arizona State Retirement System raised its position in shares of agilon health by 2.5% in the 2nd quarter. Arizona State Retirement System now owns 85,989 shares of the company’s stock worth $562,000 after acquiring an additional 2,070 shares in the last quarter. Swiss National Bank lifted its position in shares of agilon health by 0.6% during the 1st quarter. Swiss National Bank now owns 602,800 shares of the company’s stock valued at $3,677,000 after acquiring an additional 3,400 shares during the period. J.Safra Asset Management Corp boosted its stake in agilon health by 626.1% during the second quarter. J.Safra Asset Management Corp now owns 4,204 shares of the company’s stock worth $27,000 after acquiring an additional 3,625 shares in the last quarter. Neo Ivy Capital Management acquired a new position in shares of agilon health during the fourth quarter valued at about $47,000. Finally, Renaissance Capital LLC boosted its position in shares of agilon health by 3.0% during the 1st quarter. Renaissance Capital LLC now owns 191,122 shares of the company’s stock worth $1,166,000 after purchasing an additional 5,551 shares in the last quarter.

About agilon health

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.